WO1995016036A3 - CHAINE β DE RECEPTEURS D'IFN-η ET LEURS DERIVES - Google Patents

CHAINE β DE RECEPTEURS D'IFN-η ET LEURS DERIVES Download PDF

Info

Publication number
WO1995016036A3
WO1995016036A3 PCT/US1994/014277 US9414277W WO9516036A3 WO 1995016036 A3 WO1995016036 A3 WO 1995016036A3 US 9414277 W US9414277 W US 9414277W WO 9516036 A3 WO9516036 A3 WO 9516036A3
Authority
WO
WIPO (PCT)
Prior art keywords
ifn
ηreceptor
derivatives
chain
invention concerns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1994/014277
Other languages
English (en)
Other versions
WO1995016036A2 (fr
Inventor
Michel Aguet
Ruth Boehni
Silvio Hemmi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP7516386A priority Critical patent/JPH09506263A/ja
Priority to EP95908418A priority patent/EP0733111A1/fr
Publication of WO1995016036A2 publication Critical patent/WO1995016036A2/fr
Publication of WO1995016036A3 publication Critical patent/WO1995016036A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7156—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Cette invention se rapporte à de nouveaux polypeptides constituant des sous-unités de récepteurs. Cette invention concerne plus particulièrement de nouvelles protéines transmembranaires qui appartiennent à la famille des récepteurs de l'interféron et qui sont des cofacteurs à spécificité d'espèce nécessaires pour la transduction du signal de l'interféron-η (IFN-η).
PCT/US1994/014277 1993-12-09 1994-12-07 CHAINE β DE RECEPTEURS D'IFN-η ET LEURS DERIVES Ceased WO1995016036A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP7516386A JPH09506263A (ja) 1993-12-09 1994-12-07 ＩＦＮ−γレセプターβ−鎖およびその誘導体
EP95908418A EP0733111A1 (fr) 1993-12-09 1994-12-07 CHAINE $g(b) DE RECEPTEURS D'IFN-$g(g) ET LEURS DERIVES

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16459693A 1993-12-09 1993-12-09
US08/164,596 1993-12-09

Publications (2)

Publication Number Publication Date
WO1995016036A2 WO1995016036A2 (fr) 1995-06-15
WO1995016036A3 true WO1995016036A3 (fr) 1995-08-31

Family

ID=22595201

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1994/014277 Ceased WO1995016036A2 (fr) 1993-12-09 1994-12-07 CHAINE β DE RECEPTEURS D'IFN-η ET LEURS DERIVES

Country Status (4)

Country Link
EP (1) EP0733111A1 (fr)
JP (1) JPH09506263A (fr)
CA (1) CA2177471A1 (fr)
WO (1) WO1995016036A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2169849A1 (fr) * 1993-08-20 1995-03-02 Sidney Pestka Fonction de facteur accessoire pour interferon gamma et son recepteur
US20020025316A1 (en) 1995-08-18 2002-02-28 Ferguson Mark Williams James Pharmaceutical composition containing inhibitors of interferon-gamma
GB2304342A (en) * 1995-08-18 1997-03-19 Univ Manchester Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma
WO1999046379A2 (fr) * 1998-03-09 1999-09-16 Schering Corporation Proteines receptrices humaines; reactifs et procedes associes
US6586228B1 (en) 1998-03-09 2003-07-01 Schering Corporation Polynucleotides encoding DIRS1
US6348316B1 (en) 2000-04-12 2002-02-19 Cedars-Sinai Medical Center Genetic testing for determining the risk of pouchitis development
US7608430B2 (en) 2005-07-08 2009-10-27 Regeneron Pharmaceuticals, Inc. Interferon-γ antagonists and therapeutic uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005847A1 (fr) * 1993-08-20 1995-03-02 University Of Medicine & Dentistry Of New Jersey Fonction du facteur accessoire de l'interferon gamma et de son recepteur

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005847A1 (fr) * 1993-08-20 1995-03-02 University Of Medicine & Dentistry Of New Jersey Fonction du facteur accessoire de l'interferon gamma et de son recepteur

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
ANNUAL MEETING OF THE ISICR ON THE INTERFERON SYSTEM, TOKYO, JAPAN ; OCTOBER 24-28 ,1993. *
ANNUAL MEETING OF THE ISICR, TOKYO, JAPAN; OCTOBER 24-28, 1993. *
J. SOH ET AL: "Identification and sequence of an accessory factor required for activation of the human interferon gamma receptor", CELL, vol. 76, 11 March 1994 (1994-03-11), CAMBRIDGE, NA US, pages 793 - 802 *
J. SOH ET AL: "Identification of a yeast artificial chromosome clone encoding an accessory factor for the human interferon gamma receptor: Evidence for multiple accessory factors", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 90, September 1993 (1993-09-01), WASHINGTON US, pages 8737 - 8741 *
J.R. COOK ET AL: "Localization of the human IFN-gamma receptor accessory factor gene and discovery of a new accessory factor by chromosomal fragmentation", JOURNAL OF INTERFERON RESEARCH , VOL. 13, SUPPL. 1,, September 1993 (1993-09-01), pages S49 *
S. HEMMI ET AL: "A novel member of the Interferon receptor family complements functionality of the murine interferon gamma receptor in human cells", CELL, vol. 76, 11 March 1994 (1994-03-11), CAMBRIDGE, NA US, pages 803 - 810 *
S. HEMMI ET AL: "Expression cloning of a species-specific interferon-gamma receptor accessory component", JOURNAL OF INTERFERON RESEARCH VOL. 13 , SUPPL 1, September 1993 (1993-09-01), pages S55 *
U. KALINA ET AL: "The human gamma interferon receptor accessory factor encoded by chromosome 21 transduces the signal for the induction of 2',5'-Oligoadenylate-synthetase, resistance to virus cytopathic effect , and major histocompatibility complex class I antigens", JOURNAL OF VIROLOGY, vol. 67, no. 3, March 1993 (1993-03-01), pages 1702 - 1706 *
Y. HIBINO ET AL: "Expression and reconstitution of a biologically active mouse Interferon gamma receptor in hamster cells", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 266, no. 11, 15 April 1991 (1991-04-15), BALTIMORE, MD US, pages 6948 - 6951 *

Also Published As

Publication number Publication date
JPH09506263A (ja) 1997-06-24
CA2177471A1 (fr) 1995-06-15
WO1995016036A2 (fr) 1995-06-15
EP0733111A1 (fr) 1996-09-25

Similar Documents

Publication Publication Date Title
CA2200423A1 (fr) Nouveaux recepteurs d'oestrogene
EP0397633A3 (fr) Protéine liant la fibronectine et sa préparation
AU1865397A (en) Transferrin receptor genes of moraxella
AU4855393A (en) Polypeptides of g-coupled receptor proteins, and compositions and methods thereof
AU688210B2 (en) Recombinant obese (Ob) proteins
ATE313626T1 (de) Mu-1, ein mitglied der zytokinrezeptor-familie
WO1995010628A3 (fr) Transduction de signaux par l'intermediaire de cd28
NO931955L (no) Reseptorer for leukemiinhiberende faktor
WO1995033059A3 (fr) Recepteur de l'oncostatine m
CA2220447A1 (fr) Nouveaux procedes de recuperation et de purification de proteines de fusion
AU1628501A (en) Novel peptide dimers as agonists of the erythropoietin (epo) receptor, and associated methods of synthesis and use
CA2011450A1 (fr) Chaine beta recombinante du recepteur d'il-2
EP0973893A4 (fr) Polypeptide lie a un peptide amyloide-beta intracellulaire (erab)
AU6723796A (en) Traf inhibitors
AU5759399A (en) Peptide derivative
WO1995016036A3 (fr) CHAINE β DE RECEPTEURS D'IFN-η ET LEURS DERIVES
WO1998057983A3 (fr) Proteine de mammifere de type facteur de croissance nerveuse
WO1997012985A3 (fr) Agonistes multifonctionnels des recepteurs hematopoietiques
WO1998017810A3 (fr) Agonistes recepteurs hematopoietiques chimeriques multifonctionnels
EP0345056A3 (fr) Antagonistes de la sérotonine
AU6308801A (en) Mu-1, member of the cytokine receptor family
CA2071950A1 (fr) Proteine fixatrice du collagene et sa preparation
EP0779361A3 (fr) Forme tronquée de la protéine inhibitrice kappa B, production récombinante et utilisation
WO2000058465A3 (fr) Analogues polypeptidiques de flint
EP0372503A3 (fr) Peptides anticoagulants

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2177471

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1995908418

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1995908418

Country of ref document: EP

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i
WWW Wipo information: withdrawn in national office

Ref document number: 1995908418

Country of ref document: EP